These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31815037)
61. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
62. YEATS4 is associated with poor prognosis and promotes epithelial-to-mesenchymal transition and metastasis by regulating ZEB1 expression in breast cancer. Li Y; Li L; Wu J; Qin J; Dai X; Jin T; Xu J Am J Cancer Res; 2021; 11(2):416-440. PubMed ID: 33575079 [TBL] [Abstract][Full Text] [Related]
63. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer. Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272 [TBL] [Abstract][Full Text] [Related]
64. The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma. Tang J; Shi H; Li H; Zhen T; Dong Y; Zhang F; Yang Y; Han A Tumour Biol; 2016 Aug; 37(8):10287-301. PubMed ID: 26842923 [TBL] [Abstract][Full Text] [Related]
65. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related]
66. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes. Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945 [TBL] [Abstract][Full Text] [Related]
67. MeCP2 Promotes Colorectal Cancer Metastasis by Modulating ZEB1 Transcription. Luo D; Ge W Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210086 [No Abstract] [Full Text] [Related]
68. USP51 promotes deubiquitination and stabilization of ZEB1. Zhou Z; Zhang P; Hu X; Kim J; Yao F; Xiao Z; Zeng L; Chang L; Sun Y; Ma L Am J Cancer Res; 2017; 7(10):2020-2031. PubMed ID: 29119051 [TBL] [Abstract][Full Text] [Related]
69. Nucleobindin-2 enhances the epithelial-mesenchymal transition in renal cell carcinoma. Tao R; Niu WB; Dou PH; Ni SB; Yu YP; Cai LC; Wang XY; Li SY; Zhang C; Luo ZG Oncol Lett; 2020 Jun; 19(6):3653-3664. PubMed ID: 32391090 [TBL] [Abstract][Full Text] [Related]
70. Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer. Liu XJ; Liu WL; Yang FM; Yang XQ; Lu XF Onco Targets Ther; 2015; 8():2101-9. PubMed ID: 26316779 [TBL] [Abstract][Full Text] [Related]
71. Helicobacter pylori Infection-Induced Hepatoma-Derived Growth Factor Regulates the Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells. Liu CJ; Wang YK; Kuo FC; Hsu WH; Yu FJ; Hsieh S; Tai MH; Wu DC; Kuo CH Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30513684 [TBL] [Abstract][Full Text] [Related]
72. BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway. Guo Y; Xu H; Huang M; Ruan Y J Cell Commun Signal; 2023 Sep; 17(3):757-772. PubMed ID: 36574142 [TBL] [Abstract][Full Text] [Related]
73. Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression. Wang WL; Hong GC; Chien PJ; Huang YH; Lee HT; Wang PH; Lee YC; Chang WW Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33334065 [TBL] [Abstract][Full Text] [Related]
74. Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9. Li Y; Liu X; Lin X; Zhao M; Xiao Y; Liu C; Liang Z; Lin Z; Yi R; Tang Z; Liu J; Li X; Jiang Q; Li L; Xie Y; Liu Z; Fang W Signal Transduct Target Ther; 2019; 4():48. PubMed ID: 31754475 [TBL] [Abstract][Full Text] [Related]
75. NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth. Liu S; Zhang Y; Cui S; Song D; Li B; Chen Q; Yao G; Gong B Cancer Cell Int; 2021 Nov; 21(1):605. PubMed ID: 34774047 [TBL] [Abstract][Full Text] [Related]
76. A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy. Figiel S; Bery F; Chantôme A; Fontaine D; Pasqualin C; Maupoil V; Domingo I; Guibon R; Bruyère F; Potier-Cartereau M; Vandier C; Fromont G; Mahéo K Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752242 [TBL] [Abstract][Full Text] [Related]
77. Retraction Note: Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis. Han J; Xie C; Pei T; Wang J; Lan Y; Huang K; Cui Y; Wang F; Zhang J; Pan S; Liang Y; Zhen T; Song R; Sun B; Li Y; Shi H; Yang G; Liu X; Zhu M; Wang Y; Li K; Liu Y; Meng F; Liao F; Meng X; Hong X; Liu L Cell Death Dis; 2024 Jun; 15(6):394. PubMed ID: 38839797 [No Abstract] [Full Text] [Related]
78. Retraction Note: HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma. Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L J Exp Clin Cancer Res; 2024 Aug; 43(1):246. PubMed ID: 39210426 [No Abstract] [Full Text] [Related]
79. Correction to: A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma. Song Y; Hu Z; Long H; Peng Y; Zhang X; Que T; Zheng S; Li Z; Wang G; Yi L; Liu Z; Fang W; Qi S J Neurooncol; 2020 Sep; 149(3):557-560. PubMed ID: 33030654 [TBL] [Abstract][Full Text] [Related]
80. Corrigendum to "LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway" [Cancer Lett.374 (2016) 261-271]. Zhan HX; Wang Y; Li C; Xu JW; Zhou B; Zhu JK; Han HF; Wang L; Wang YS; Hu SY Cancer Lett; 2024 Nov; 604():217239. PubMed ID: 39317594 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]